Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Johnson & JohnsonSinovac Biotech
SymbolNYSE:JNJNASDAQ:SVA
Price Information
Current Price$162.24$6.47
52 Week RangeBuyN/A
MarketRank™
Overall Score2.70.6
Analysis Score3.40.0
Community Score2.52.6
Dividend Score4.20.0
Ownership Score1.70.0
Earnings & Valuation Score1.90.6
Analyst Ratings
Consensus RecommendationBuyN/A
Consensus Price Target$182.62N/A
% Upside from Price Target12.56% upsideN/A
Trade Information
Market Cap$427.13 billion$639.88 million
Beta0.739.67
Average Volume8,221,131N/A
Sales & Book Value
Annual Revenue$82.06 billion$246.05 million
Price / Sales5.212.60
Cashflow$11.83 per share$0.50 per share
Price / Cash13.7112.85
Book Value$22.60 per share$3.56 per share
Price / Book7.181.82
Profitability
Net Income$15.12 billion$44.93 million
EPS$8.68N/A
Trailing P/E Ratio25.5135.94
Forward P/E Ratio18.25
P/E Growth3.06N/A
Net Margins21.01%9.36%
Return on Equity (ROE)34.64%7.12%
Return on Assets (ROA)13.40%4.83%
Dividend
Annual Payout$4.04N/A
Dividend Yield2.49%N/A
Three-Year Dividend Growth19.88%N/A
Payout Ratio46.54%N/A
Years of Consecutive Dividend Growth59 YearsN/A
Debt
Debt-to-Equity Ratio0.51%0.06%
Current Ratio1.48%2.19%
Quick Ratio1.24%1.90%
Ownership Information
Institutional Ownership Percentage67.25%12.06%
Insider Ownership Percentage0.27%N/A
Miscellaneous
Employees134,500910
Shares Outstanding2.63 billion98.90 million
Next Earnings Date4/20/2021 (Confirmed)6/29/2021 (Estimated)
OptionableOptionableOptionable
SourceHeadline
Brazil sees 1,803 COVID-19 deaths; Chinese vaccine found 50.7% effective against variantBrazil sees 1,803 COVID-19 deaths; Chinese vaccine found 50.7% effective against variant
finance.yahoo.com - April 11 at 6:25 PM
UPDATE 1-Egypt to produce up to 80 mln Sinovac vaccine doses annually- ministerUPDATE 1-Egypt to produce up to 80 mln Sinovac vaccine doses annually- minister
finance.yahoo.com - April 8 at 5:51 PM
Egypt to produce up to 60 mln Sinovac vaccine doses annually- ministerEgypt to produce up to 60 mln Sinovac vaccine doses annually- minister
finance.yahoo.com - April 8 at 12:51 PM
UPDATE 1-Turkey begins administering Pfizer/BioNTech COVID-19 shotsUPDATE 1-Turkey begins administering Pfizer/BioNTech COVID-19 shots
finance.yahoo.com - April 2 at 4:45 PM
Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 VaccineSinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
businesswire.com - April 2 at 6:44 AM
Sinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 VaccineSinovac Announced Buildup of Two Billion Annual Capacity of Its COVID-19 Vaccine
finance.yahoo.com - April 2 at 6:44 AM
China Sinovac says it reached 2 bln doses annual capacity for COVID-19 vaccineChina Sinovac says it reached 2 bln doses annual capacity for COVID-19 vaccine
finance.yahoo.com - April 1 at 10:49 PM
China Sends 1st Batch Of Sinovac Biotech Vaccine To Ukraine - EmbassyChina Sends 1st Batch Of Sinovac Biotech Vaccine To Ukraine - Embassy
ukranews.com - March 27 at 12:23 AM
100 mln doses of China Sinopharms COVID-19 vaccines supplied globally100 mln doses of China Sinopharm's COVID-19 vaccines supplied globally
finance.yahoo.com - March 26 at 2:22 PM
Erdogan says he reminded Chinese minister that Turkey expects 50 mln doses of COVID-19 vaccinesErdogan says he reminded Chinese minister that Turkey expects 50 mln doses of COVID-19 vaccines
finance.yahoo.com - March 26 at 9:20 AM
UPDATE 1-Erdogan says he raised vaccine shipment delays with ChinaUPDATE 1-Erdogan says he raised vaccine shipment delays with China
finance.yahoo.com - March 26 at 9:20 AM
UPDATE 1-China triples output of COVID-19 vaccines from early Feb - XinhuaUPDATE 1-China triples output of COVID-19 vaccines from early Feb - Xinhua
finance.yahoo.com - March 24 at 2:14 AM
COVID SCIENCE-UK variant can cause serious heart problem in pets; Sinovac vaccine appears safe in childrenCOVID SCIENCE-UK variant can cause serious heart problem in pets; Sinovac vaccine appears safe in children
finance.yahoo.com - March 22 at 7:26 PM
Egypt aims for deal to produce Sinovac COVID-19 vaccinesEgypt aims for deal to produce Sinovac COVID-19 vaccines
finance.yahoo.com - March 22 at 2:25 PM
Sinovac COVID-19 vaccine appears safe, triggers antibodies in trial in children -researcherSinovac COVID-19 vaccine appears safe, triggers antibodies in trial in children -researcher
finance.yahoo.com - March 22 at 2:25 PM
Sinovac has supplied 160 mln COVID-19 vaccine doses to 18 countries and regions - CEOSinovac has supplied 160 mln COVID-19 vaccine doses to 18 countries and regions - CEO
nasdaq.com - March 22 at 9:25 AM
Singapore talking to AstraZeneca about vaccineSingapore talking to AstraZeneca about vaccine
finance.yahoo.com - March 22 at 4:24 AM
UPDATE 2-China steps up COVID-19 vaccination, considers differentiated visa policiesUPDATE 2-China steps up COVID-19 vaccination, considers differentiated visa policies
finance.yahoo.com - March 21 at 7:18 AM
UPDATE 2-Mexico expects U.S. response to AstraZeneca vaccine request on FridayUPDATE 2-Mexico expects U.S. response to AstraZeneca vaccine request on Friday
finance.yahoo.com - March 16 at 12:36 PM
Brazils Butantan institute delivers 3.3 mln new COVID vaccine dosesBrazil's Butantan institute delivers 3.3 mln new COVID vaccine doses
finance.yahoo.com - March 15 at 3:27 PM
Hong Kong widens vaccine scheme to people over 30, domestic helpersHong Kong widens vaccine scheme to people over 30, domestic helpers
finance.yahoo.com - March 15 at 9:11 AM
China eases visa rules in Philippines for recipients of its vaccinesChina eases visa rules in Philippines for recipients of its vaccines
finance.yahoo.com - March 15 at 9:11 AM
Mexico gets shipment of million vaccine doses from Chinas SinovacMexico gets shipment of million vaccine doses from China's Sinovac
finance.yahoo.com - March 13 at 10:13 AM
Preliminary data indicates Sinovac COVID-19 vaccine effective against Brazilian P1 variant - officialPreliminary data indicates Sinovac COVID-19 vaccine effective against Brazilian P1 variant - official
finance.yahoo.com - March 10 at 1:13 PM
UPDATE 1-Preliminary data indicates Sinovac COVID-19 vaccine effective against Brazilian P1 variant - officialUPDATE 1-Preliminary data indicates Sinovac COVID-19 vaccine effective against Brazilian P1 variant - official
finance.yahoo.com - March 10 at 1:13 PM
DateCompanyBrokerageAction
1/27/2021Johnson & JohnsonJPMorgan Chase & Co.Boost Price Target
1/27/2021Johnson & JohnsonCredit Suisse GroupBoost Price Target
1/27/2021Johnson & JohnsonRaymond JamesBoost Price Target
1/27/2021Johnson & JohnsonCowenBoost Price Target
1/27/2021Johnson & JohnsonMorgan StanleyBoost Price Target
1/27/2021Johnson & JohnsonSVB LeerinkBoost Price Target
1/27/2021Johnson & JohnsonWells Fargo & CompanyBoost Price Target
1/26/2021Johnson & JohnsonCantor FitzgeraldBoost Price Target
8/19/2020Johnson & JohnsonStifel NicolausDowngrade
7/20/2020Johnson & JohnsonBank of AmericaReiterated Rating
7/20/2020Johnson & JohnsonIndependent ResearchUpgrade
7/17/2020Johnson & JohnsonCitigroupBoost Price Target
4/29/2020Johnson & JohnsonBarclaysBoost Price Target
(Data available from 4/18/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.